Karren Williams

887 total citations · 1 hit paper
12 papers, 589 citations indexed

About

Karren Williams is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Karren Williams has authored 12 papers receiving a total of 589 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cardiology and Cardiovascular Medicine, 5 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Surgery. Recurrent topics in Karren Williams's work include Lipid metabolism and disorders (7 papers), Pancreatitis Pathology and Treatment (3 papers) and Diabetes and associated disorders (2 papers). Karren Williams is often cited by papers focused on Lipid metabolism and disorders (7 papers), Pancreatitis Pathology and Treatment (3 papers) and Diabetes and associated disorders (2 papers). Karren Williams collaborates with scholars based in United States, Netherlands and Canada. Karren Williams's co-authors include Andrés Digenio, Veronica J. Alexander, Joseph L. Witztum, Louis O’Dea, Dirk Blom, Linda Hemphill, Richard S. Geary, Erik S.G. Stroes, Éric Bruckert and Steven G. Hughes and has published in prestigious journals such as New England Journal of Medicine, SLEEP and Current Medical Research and Opinion.

In The Last Decade

Karren Williams

11 papers receiving 574 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome

2019 416 citations Joseph L. Witztum, Daniel Gaudet et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karren Williams United States	6	334	261	248	145	106	12	589
José-Miguel González-Clemente Spain	11	83 0.2×	49 0.2×	146 0.6×	51 0.4×	27 0.3×	19	353
Arthi Kumaravel United States	9	34 0.1×	210 0.8×	39 0.2×	79 0.5×	37 0.3×	14	426
Pnina Hertz Israel	12	95 0.3×	60 0.2×	388 1.6×	98 0.7×	59 0.6×	18	525
Mary M. Chen United States	6	132 0.4×	402 1.5×	102 0.4×	82 0.6×	14 0.1×	9	656
Sabrina Pilia Italy	15	77 0.2×	72 0.3×	373 1.5×	91 0.6×	15 0.1×	21	598
Claire Jones United Kingdom	6	68 0.2×	64 0.2×	150 0.6×	60 0.4×	23 0.2×	12	363
Mohamed Chikri France	12	55 0.2×	156 0.6×	292 1.2×	335 2.3×	61 0.6×	19	824
Víctor Martínez United States	10	105 0.3×	47 0.2×	469 1.9×	193 1.3×	40 0.4×	18	535
Antoinette Tuthill Ireland	10	16 0.0×	143 0.5×	162 0.7×	179 1.2×	29 0.3×	21	466
Jennifer McGinniss United States	9	115 0.3×	102 0.4×	70 0.3×	31 0.2×	37 0.3×	29	249

Countries citing papers authored by Karren Williams

Since Specialization

Citations

This map shows the geographic impact of Karren Williams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karren Williams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karren Williams more than expected).

Fields of papers citing papers by Karren Williams

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karren Williams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karren Williams. The network helps show where Karren Williams may publish in the future.

Co-authorship network of co-authors of Karren Williams

This figure shows the co-authorship network connecting the top 25 collaborators of Karren Williams. A scholar is included among the top collaborators of Karren Williams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karren Williams. Karren Williams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Thorndike, Frances P., et al.. (2021). 664 Characteristics of respondents to a virtual trial of a digital behavioral treatment for insomnia during the COVID-19 pandemic. SLEEP. 44(Supplement_2). A259–A260.

Xiong, Xiaorui, Robert Gerwien, Alice A. Kuo, et al.. (2020). Real-world evidence for a prescription digital therapeutic to treat opioid use disorder. Current Medical Research and Opinion. 37(2). 175–183. 36 indexed citations

Witztum, Joseph L., Daniel Gaudet, Steven D. Freedman, et al.. (2019). Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome. New England Journal of Medicine. 381(6). 531–542. 416 indexed citations breakdown →

Blom, Dirk, Louis O’Dea, Andrés Digenio, et al.. (2018). Characterizing familial chylomicronemia syndrome: Baseline data of the APPROACH study. Journal of clinical lipidology. 12(5). 1234–1243.e5. 58 indexed citations

Williams, Karren, et al.. (2018). Evaluating the impact of peer support and connection on the quality of life of patients with familial chylomicronemia syndrome. Expert Opinion on Orphan Drugs. 6(8). 497–505. 4 indexed citations

Gelrud, Andrés, Andrés Digenio, Veronica J. Alexander, et al.. (2018). Treatment with Volanesorsen (VLN) Reduced Triglycerides and Pancreatitis in Patients with FCS and sHTG vs Placebo: Results of the APPROACH and COMPASS †. Journal of clinical lipidology. 12(2). 537–537. 13 indexed citations

Williams, Karren, et al.. (2018). Evaluating the Impact of Peer Support and Connection on the Quality of Life of Patients with Familial Chylomicronemia Syndrome. Journal of clinical lipidology. 12(2). 538–539. 2 indexed citations

Blom, Dirk, Steven D. Freedman, Andrés Gelrud, et al.. (2018). Treatment with volanesorsen (VLN) reduced triglycerides and pancreatitis in patients with familial chylomicronemia syndrome (FCS) and severe hypertriglyceridemia (sHTG) vs placebo: Results of the approach and compass studies. Pancreatology. 18(4). S101–S101. 2 indexed citations

Gelrud, Andrés, Andrés Digenio, Veronica J. Alexander, et al.. (2018). Treatment with Volanesorsen (VLN) Reduced Triglycerides and Pancreatitis in Patients with FCS and sHTG vs Placebo: Results of the APPROACH and COMPASS Studies. Atherosclerosis Supplements. 32. 157–157. 4 indexed citations

10.

Gelrud, Andrés, et al.. (2017). The burden of familial chylomicronemia syndrome from the patients’ perspective. Expert Review of Cardiovascular Therapy. 15(11). 879–887. 28 indexed citations

11.

Williams, Karren, et al.. (2001). Head injury and alexithymia: implications for family practice care. Brain Injury. 15(4). 349–356. 24 indexed citations

12.

Williams, Karren, et al.. (1996). The Re-Employment of the Sexual Addict/Offender Program: An Evaluation. Journal of Applied Rehabilitation Counseling. 27(1). 33–36. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact